180 Life Sciences Corp. (ATNF)

1.17

0.00 (0.00%)

At close: Feb 28, 2025, 3:59 PM

1.17

0.43%

After-hours: Feb 28, 2025, 04:00 PM EST

180 Life Sciences Cash Flow Statement

Table Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18	FY17
Net Income	-19.94M	-38.73M	-20.32M	-10.88M	-25.39M	-14.5M	123.76K
Depreciation & Amortization	105.67K	109K	109.95K	125.33K	72.24K	23.08K	n/a
Stock-Based Compensation	2.28M	2.97M	5M	1.12M	13.3M	4.6M	n/a
Other Working Capital	-300.51K	1.51M	-3.08M	105.35K	140.99K	-117.52K	53.56K
Other Non-Cash Items	8.99M	22.08M	6.82M	3.46M	5.68M	6.07M	-567.56K
Deferred Income Tax	-2.35M	-942.75K	-24.8K	-20.43K	-9.5K	n/a	n/a
Change in Working Capital	-14.1K	2.72M	-8.81M	2.33M	3.04M	-117.52K	-53.56K
Operating Cash Flow	-10.92M	-12.13M	-19.37M	-3.87M	-3.32M	-3.92M	-497.36K
Capital Expenditures	3.00	n/a	n/a	n/a	-144.4K	-30.83K	n/a
Acquisitions	n/a	n/a	n/a	3.01M	86.08K	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	10.28M	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	1.2M	-649.83K	-60K	-115.92M
Investing Cash Flow	n/a	n/a	n/a	14.49M	-708.15K	-90.83K	-115.92M
Debt Repayment	-288.07K	-530.14K	800.85K	319.43K	2.69M	n/a	n/a
Common Stock Repurchased	n/a	-1.01M	n/a	-9.01M	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	196.47K	11.4M	-2.06M	-119.36K	1.26M	4.77M	116.78M
Financial Cash Flow	5.91M	10.87M	25.41M	-8.73M	3.94M	4.77M	116.78M
Net Cash Flow	-4.99M	-1.25M	6.12M	2.03M	-483.82K	-157.51K	361.14K
Free Cash Flow	-10.92M	-12.13M	-19.37M	-3.87M	-3.46M	-3.95M	-497.36K